Prophylactic Sildenafil in Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Pilot Randomized, Double-Blinded, Placebo-Controlled Trial

BACKGROUND: Bronchopulmonary dysplasia (BPD) is the need for oxygen therapy at 36 weeks postmenstrual age (PMA). Sildenafil has been shown to enhance the lung alveolarization and vascularization in newborn animal models after lung injury and has possible therapeutic potential for the prevention of B...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Drug Investig
Autors principals: Abounahia, Fouad F., Abu-Jarir, Rawia, Abounahia, Mohamed F., Al-Badriyeh, Daoud, Abushanab, Dina, Abu-Ghalwa, Mahmoud, Mansour, Ashraf, Kurdi, Bader, Al-Rifai, Hilal
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2019
Matèries:
Original Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6800408/
https://ncbi.nlm.nih.gov/pubmed/31414269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-019-00834-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars